{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T10:15:12Z","timestamp":1648894512781},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1982,1,1]],"date-time":"1982-01-01T00:00:00Z","timestamp":378691200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1982]]},"DOI":"10.1007\/bf00637493","type":"journal-article","created":{"date-parts":[[2004,11,26]],"date-time":"2004-11-26T14:29:08Z","timestamp":1101479348000},"page":"483-489","source":"Crossref","is-referenced-by-count":2,"title":["Comparative evaluation of the new vasodilator carprazidil and minoxidil in the treatment of moderate to severe hypertension"],"prefix":"10.1007","volume":"23","author":[{"given":"M. G.","family":"Bianchetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Weidmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Boehringer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Link","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Schiffl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Beretta-Piccoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. P.","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"625","volume":"111","author":"P Weidmann","year":"1981","unstructured":"Weidmann P (1981) Neuere blutdrucksenkende Medikamente. Schweiz Med Wochenschr 111: 625?637","journal-title":"Schweiz Med Wochenschr"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0140-6736(77)92958-0","volume":"1","author":"RK Ferguson","year":"1977","unstructured":"Ferguson RK, Turini GA, Brunner HR, Gavras H (1977) A specific orally active inhibitor of angiotensin-converting enzyme in man. Lancet 1: 775?778","journal-title":"Lancet"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000181366","volume":"21","author":"GW Keusch","year":"1978","unstructured":"Keusch GW, Weidmann P, Campese V, Lee DBN, Upham AT, Massry SG (1978) Minoxidil therapy in refractory hypertension. Analysis of 155 cases. Nephron 21: 1?5","journal-title":"Nephron"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1001\/jama.1978.03280470043020","volume":"239","author":"HC Mitchell","year":"1978","unstructured":"Mitchell HC, Pettinger WA (1978) Long-term treatment of refractory hypertension with Minoxidil. J Am Med Assoc 239: 2131?2138","journal-title":"J Am Med Assoc"},{"key":"CR5","unstructured":"Editorial (1980) Captopril: benefits and risks in severe hypertension. Lancet 2: 129?130"},{"key":"CR6","first-page":"624","volume":"216","author":"M Gerold","year":"1981","unstructured":"Gerold M, Eigenmann R, Hefti F, Daum A, Haeusler G (1981) Cardiovascular effects of a novel vasoactive antihypertensive agent, Ro 12-4713. J Pharmacol Exp Ther 216: 624?633","journal-title":"J Pharmacol Exp Ther"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF00544594","volume":"20","author":"M Grimm","year":"1981","unstructured":"Grimm M, Weidmann P, Meier A, Schiffl H, Ziegler WH, Reubi FC (1981) Acute effects of a new vasodilator, Ro 12-4713, on blood pressure, plasma renin activity, aldosterone and catecholamine levels, and renal function in hypertensive and normal subjects. Eur J Clin Pharmacol 20: 169?177","journal-title":"Eur J Clin Pharmacol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF00607141","volume":"20","author":"M Grimm","year":"1981","unstructured":"Grimm M, Weidmann P, Meier A, Schiffl H, Ziegler WH (1981) Chronic treatment with the new potent vasodilator Ro 12-4713 in moderate to severe hypertension: effects on blood pressure, endocrine function, sodium and plasma volume. Eur J Clin Pharmacol 20: 79?84","journal-title":"Eur J Clin Pharmacol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF00562798","volume":"19","author":"D Chu","year":"1981","unstructured":"Chu D, Cocco G, Strozzi C, Vallini R, Nonato M, Amerin R (1981) Antihypertensive effects of a novel peripheral vasodilator, Ro 12-4713. Eur J Clin Pharmacol 19: 233?238","journal-title":"Eur J Clin Pharmacol"},{"key":"CR10","unstructured":"Amann FW, Conen D, B\u00fchler FR, Dubach UC (1980) Efficacy and tolerability of the new long-acting vasodilator Ro 12-4713 in severe hypertensive patients. Proc 7th Int Soc Hypertension, New Orlears, USA, May 11?14, p 4"},{"issue":"Suppl","key":"CR11","first-page":"2","volume":"38","author":"P Weidmann","year":"1981","unstructured":"Weidmann P (1981) Rationale Diagnostik bei Hypertonie. Ther Umsch 38 [Suppl]: 2?16","journal-title":"Ther Umsch"},{"key":"CR12","doi-asserted-by":"crossref","unstructured":"National diabetes data group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28: 1039?1057","DOI":"10.2337\/diab.28.12.1039"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/BF01476959","volume":"55","author":"P Weidmann","year":"1977","unstructured":"Weidmann P, De Ch\u00e2tel R, Schiffmann A, Bachmann E, Beretta-Piccoli C, Ziegler WH, Vetter W, Reubi FC (1977) Interrelations among age and plasma renin, aldosterone and cortisol, urinary catecholamines and the body sodium\/volume state in normal man. Klin Wochenschr 55: 725?733","journal-title":"Klin Wochenschr"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/ki.1978.171","volume":"14","author":"P Weidmann","year":"1978","unstructured":"Weidmann P, Beretta-Piccoli C, Ziegler WH, Keusch G, Gl\u00fcck Z (1978) Age versus urinary sodium for judging renin, aldosterone and catecholamine levels. Studies in normal subjects and patients with essential hypertension. Kidney Int 14: 619?628","journal-title":"Kidney Int"},{"key":"CR15","first-page":"1146A","volume":"62","author":"WK Kirkendall","year":"1980","unstructured":"Kirkendall WK, Feinleib M, Freis ED, Mark AL (1980) Recommandations for human blood pressure determination by sphygmomanometer. Circulation 62: 1146A-1155A","journal-title":"Circulation"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/ki.1972.34","volume":"1","author":"JE Sealey","year":"1972","unstructured":"Sealey JE, Gerten-Banes J, Laragh JH (1972) The renin system: variations in man measured by radioimmunoassay. Kidney Int 1: 240?253","journal-title":"Kidney Int"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1530\/acta.0.0740558","volume":"74","author":"W Vetter","year":"1973","unstructured":"Vetter W, Vetter H, Siegenthaler W (1973) Radioimmunoassay for aldosterone without chromatography: II. Determination of plasma aldosterone. Acta Endocrinol 74: 558?567","journal-title":"Acta Endocrinol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/0024-3205(76)90251-4","volume":"19","author":"M Prada Da","year":"1976","unstructured":"Da Prada M, Z\u00fcrcher G (1976) Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the fentomole range. Life Sci 19: 1161?1174","journal-title":"Life Sci"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.RES.47.1.1","volume":"47","author":"S Wallenstein","year":"1950","unstructured":"Wallenstein S, Zucker CL, Fleiss JL (1950) Some statistical methods useful in circulation research. Circ Res 47: 1?9","journal-title":"Circ Res"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/BF01747754","volume":"59","author":"A Meier","year":"1981","unstructured":"Meier A, Weidmann P, Ziegler WH (1981) Catecholamines, renin, aldosterone, and blood volume during chronic minoxidil therapy. Klin Wochenschr 59: 1231?1236","journal-title":"Klin Wochenschr"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1172\/JCI107926","volume":"55","author":"K O'Malley","year":"1975","unstructured":"O'Malley K, Velasco M, Wells J, McNay JL (1975) Control plasma renin activity and changes in sympathetic tone as determinant of minoxidil-induced increase in plasma renin activity. J Clin Invest 55: 230?235","journal-title":"J Clin Invest"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1056\/NEJM197506052922304","volume":"292","author":"WA Pettinger","year":"1975","unstructured":"Pettinger WA, Mitchell HC (1975) Renin release, saralasin and the vasodilator-betablocker drug interaction in man. N Engl J Med 292: 1214?1217","journal-title":"N Engl J Med"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/archinte.1979.03630420023010","volume":"139","author":"CE Grim","year":"1979","unstructured":"Grim CE, Luft FC, Grim CM, Klotman PE, Van Huysse JW, Weinberger MH (1979) Rapid blood pressure control with minoxidil. Acute and chronic effects on blood pressure, sodium excretion, and the renin-aldosterone system. Arch Intern Med 139: 529?533","journal-title":"Arch Intern Med"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1210\/jcem-49-6-834","volume":"49","author":"JH Pratt","year":"1979","unstructured":"Pratt JH, Grim CE, Parkinson CA (1979) Minoxidil increases aldosterone metabolic clearance in hypertensive patients. J Clin Endocrinol Metab 49: 834?837","journal-title":"J Clin Endocrinol Metab"},{"key":"CR25","first-page":"104","volume":"107","author":"C Beretta-Piccoli","year":"1977","unstructured":"Beretta-Piccoli C, Weidmann P, De Ch\u00e2tel R, Reubi FC (1977) Beziehungen zwischen Blutdruck, Blutvolumen und Plasmarenin w\u00e4hrend Diuretika-Therapie bei essentieller Hypertonie: Vergleich des Mineralocorticoid-Antagonisten Spironolacton mit dem ?Schleifendiuretikum? Mefrusid. Schweiz Med Wochenschr 107: 104?115","journal-title":"Schweiz Med Wochenschr"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/0002-9149(75)90168-X","volume":"36","author":"FR B\u00fchler","year":"1975","unstructured":"B\u00fchler FR, Burkart F, L\u00fctold BE, K\u00fcng M, Marbet G, Pfisterer M (1975) Antihypertensive beta blocking action as related to renin and age: a pharmacological tool to identify pathogenic mechanisms in essential hypertension. Am J Cardiol 36: 653?669","journal-title":"Am J Cardiol"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/BF01614293","volume":"54","author":"P Weidmann","year":"1976","unstructured":"Weidmann P, Beretta-Piccoli C, Ziegler WH, Hirsch D, Reubi FC (1976) Interrelations between blood pressure, blood volume, plasma renin and urinary catecholamines during betablockade in essential hypertension. Klin Wochenschr 54: 765?773","journal-title":"Klin Wochenschr"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2165\/00003495-198122040-00001","volume":"22","author":"VM Campese","year":"1981","unstructured":"Campese VM (1981) Minoxidil: a review of its pharmacological properties and therapeutic efficacy. Drugs 22: 257?278","journal-title":"Drugs"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/BF01478605","volume":"58","author":"A Meier","year":"1980","unstructured":"Meier A, Weidmann P, Gl\u00fcck Z, Keusch G, Grimm M, Minder I, Reubi FC (1980) Vergleich von oralem Diazoxid und Minoxidil bei therapieresistenter Hypertonie. Klin Wochenschr 58: 681?687","journal-title":"Klin Wochenschr"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1365-2133.1975.tb05123.x","volume":"93","author":"JL Burton","year":"1975","unstructured":"Burton JL, Schutt WH, Caldwell IW (1975) Hypertrichosis due to diazoxide. Br J Dermatol 93: 707?711","journal-title":"Br J Dermatol"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/00007611-197704000-00023","volume":"70","author":"RN Earhart","year":"1977","unstructured":"Earhart RN, Ball J, Nuss DD, Aeling JL (1977) Minoxidil induced hypertrichosis: Treatment with calcium thioglycate depilatory. South Med J 70: 442?445","journal-title":"South Med J"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00637493.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00637493\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00637493","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T05:21:59Z","timestamp":1554441719000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00637493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1982]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1982]]}},"alternative-id":["BF00637493"],"URL":"https:\/\/doi.org\/10.1007\/bf00637493","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1982]]}}}